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Neural differentiation on synthetic scaffold materials
Busra Mammadov, Melike Sever, Mustafa O. Guler* and Ayse B. Tekinay*
The potential of stem cells to differentiate into a variety of subgroups of neural cells makes stem cell
differentiation and transplantation a promising candidate for neurodegenerative disorder therapies.
However, selective differentiation of stem cells to neurons while preventing glial scar formation is a
complex process. Mimicking the natural environment of neural tissue is pivotal, thus various synthetic
materials have been developed for this purpose. The synthetic scaffolds can direct stem cells into a neural
lineage by including extracellular factors that act on cell fate, which are mainly soluble signals, extracellu-
lar matrix proteins and physical factors (e.g. elasticity and topography). This article reviews synthetic
materials developed for neural regeneration in terms of their extracellular matrix mimicking properties.
Functionalization of synthetic materials by addition of bioactive chemical groups and adjustment of
physical properties such as topography, electroactivity and elasticity are discussed.
1. Introduction
Neurodegeneration is the progressive loss of structure and
function of nerve cells. Degeneration is a common pheno-
menon in many neurodegenerative diseases and nerve injury.
Neurodegeneration generally occurs due to the accumulation
of misfolded aggregated proteins in some parts of the aging
brain and, as a result, cell death and inflammatory damage
occur in those areas in the brain.1 Clinically, there are
different types of neurodegeneration in different neurodegen-
erative diseases. Therefore, there are some differences in the
proximal triggers and pathological markers such as Lewy
bodies in Parkinson’s disease, plaques and tangles in Alzhei-
mer’s disease, demyelination in multiple sclerosis and motor-
neuron death in ALS. On the other hand, despite different trig-
gering factors, these diseases share some overlapping down-
stream and secondary pathways such as neuroinflammation.
Adult central nervous system cells have poor regeneration
capacity, so any damage to the central nervous system might
be permanent. Lost cells cannot be replaced with new func-
tional ones, and remaining nerve cells cannot make new con-
nections after injury due to the inhibitory properties of the
extracellular matrix.2 Besides neurodegenerative disorders,
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traumatic injuries such as spinal cord injuries have destructive
effects on motor, sensory, and autonomic functions. It gene-
rally causes a permanent loss of sensation below the site of the
injury. In the case of peripheral nerve injuries, cells in the per-
ipheral nervous system have a regeneration capacity unlike the
ones in the central nervous system.
Fully restoring the functional capacities of neurons after
damage due to traumatic injuries or neurodegenerative dis-
orders is still not possible. Although conventional therapies
provide neural regeneration up to a certain level, they are not
as efficient as desired. When the neural regeneration term is
used, it refers to several different mechanisms to restore the
functions of the degenerated neural tissue. It either occurs by
the generation of new neurons from the progenitor cells resid-
ing nearby the damaged area, the generation of new synapses
by the neurons that survive after the damage or by the repair
of the axons/myelin sheets around the axons to prevent sec-
ondary cell loss after injury. It is more effective to combine
these strategies in order to achieve functional regeneration of
the nervous system. However, due to some intrinsic characteri-
stics of the nervous system such as the unproliferative nature
of neurons, the presence of progenitors in very localized areas
in low numbers along with the upregulation of inhibitory
elements upon injury leading to glial scar formation, the
regeneration capacity of the central nervous system (CNS) is
quite limited. This limited capacity of regeneration is aimed to
be improved by materials designed for stem cell culture, differ-
entiation and transplantation, which are called ‘scaffolds’.
Stem cells are promising candidates for the treatment of
neurological disorders since they can differentiate into neural
cells when induced appropriately. Their differentiation can be
enhanced by using bioactive materials, which can also be used
as vehicles for cell transplantation to the damage site. In pre-
vious studies, various synthetic materials have been analyzed
as scaffolds in vitro and in vivo for their potential to induce
neural differentiation and nerve regeneration.3–6 This review is
focused on synthetic materials developed for neural regene-
ration including polymeric materials and self-assembled
systems, and their modifications to support neural
differentiation.
Natural cues for directing cell fate consist of different
chemical, physical and biological signals in the extracellular
matrix (ECM), neighboring cell interactions, soluble factors
such as chemokines, growth factors and hormones, and the
inherited potency of the cell.7 Combination of these factors
and their interactions affects the ultimate cellular differen-
tiation mechanisms (Fig. 1). Understanding this complex
environment and mimicking it as efficiently as possible will
enable the directing of cell differentiation in a desired
manner. One way of mimicking the natural environment of
cells in vitro is to supply soluble factors in the culture media.
This approach is relatively simple but costly since it requires a
high concentration of soluble factors. Also it is not very
efficient since it does not mimic the mechanical properties of
the cells’ natural environment. Cells are embedded in tissues
in a three-dimensional (3D) manner and they can migrate or
grow extensions such as axons and dendrites of neural cells.
Physical properties of the 3D network including stiffness,
roughness and pore size are also important and should be con-
sidered while designing a synthetic system that mimics the
native tissue. As conventional in vitro cell culture surfaces
cannot provide an appropriate environment to cells, 3D
scaffolds combined with soluble signals or bioactive signals
Mustafa O. Guler
Mustafa O. Guler is a professor of
Materials Science and Nanotech-
nology at Bilkent University. He
received his PhD degree in chem-
istry from Northwestern University
in Evanston, IL, USA in 2006.
After receiving his PhD, he had
worked at the Institute for Biona-
notechnology in Medicine at
Northwestern University and
Nanotope Inc. in Chicago, IL, USA
until 2008. His research is based
on discoveries of nanostructures at
the interface of chemistry, biology,
and materials science.
Ayse B. Tekinay
Ayse B. Tekinay is a professor of
Materials Science and Nanotech-
nology at Bilkent University. She
received her PhD degree in mole-
cular biology at the Rockefeller
University, New York, USA in
2006. After receiving her PhD,
she continued her post-doctoral
studies at the Rockefeller Univer-
sity until 2009. Her research
focus is nanobiotechnology, cell-
extracellular matrix interactions,
and use of extracellular matrix
platforms for tissue regeneration
and regenerative medicine.
Fig. 1 Neural stem cell fate determination is mainly guided by extracellular
matrix molecules, soluble factors and cell-to-cell interactions.
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tethered to the surface are used to mimic the natural neural
niche.
Natural extracellular matrix proteins or synthetic scaffolds
have been used for developing 3D scaffolds to mimic the bio-
logical, chemical and mechanical properties of natural matrix
of the cells. Although natural proteins are biocompatible, it is
not easy to functionalize these scaffolds with desired bioactive
groups, or to manipulate their mechanical properties such as
stiffness. Thus, these scaffolds might not be sufficient to
direct the differentiation of cells especially into complex cells
like neurons.8–12 On the other hand, synthetic materials can
be synthesized with desired functionalities such as specific
bioactive groups, stiffness and roughness in order to mimic
the natural environment of cells.
2. Approaches in the design of synthetic
materials for neural differentiation
A variety of different methods can be used to develop scaffold
materials with desired properties, including the support of cell
survival and the induction of differentiation into desired cell
types. Besides changing the material type, nerve regeneration
studies have also focused on designing scaffolds with incor-
porated bioactivity for the induction of neurogenesis. One
approach to induce differentiation is by adding soluble indu-
cers while culturing cells on non-bioactive scaffolds. In this
approach, a scaffold is a better environment for cell survival
compared to a tissue culture plate. However, as the scaffold
itself does not include any signal for differentiation, differen-
tiation is induced solely by the soluble inducers added to the
growth media. Soluble inducers commonly used for neural
differentiation include neurotrophic factors (nerve growth
factor (NGF), brain-derived neurotrophic factor (BDNF), neuro-
trophin-3 (NT-3) etc.) and retinoic acid (RA).
Another approach is by embedding the soluble inducers
mentioned above into the scaffold in order to provide a
gradual release or by tethering these inducers to the surface of
the scaffold through functional groups, in order to provide
spatial organization to cells. In the case of gradual release, the
scaffold is not bioactive but has a role in differentiation by
releasing inducers at desired concentrations over a longer time
period. When tethering the inducers to the surface, the
scaffold is bioactive, however its bioactivity is not directly
related to the differentiation process. Bioactive groups on the
material’s surface are presented so that they bind to the
soluble inducers and present them similar to the extracellular
matrix components (such as heparan sulfate proteoglycans)
presenting growth factors to the cells. Soluble factors can also
be immobilized on material surfaces directly by covalent
attachment without the use of the growth factor affine
proteoglycans.13
Functionalization of the surface with bioactive signals is a
method used for differentiation induction directed by scaffold.
Bioactive groups can be either chemical groups inspired by the
natural environment of cells in a specific tissue, like the brain,
or functional groups of natural inducers such as peptides
found in neural differentiation-inducing proteins. Besides the
addition of bioactive signals, scaffolds can also be functio-
nalized by tuning their mechanical properties and physical
morphology in order to support neural cell survival and differ-
entiation. Since they present bioactive groups, these scaffolds
can be used alone for the induction of differentiation, depend-
ing on the complexity of the final cell type and potency of the
starting cell for differentiation into desired cell phenotypes
(Fig. 2). Such a scaffold can induce differentiation into
different neuronal subtypes. However, it might not be
sufficient for maturation of the induced cells into functional
cells. Additional inducers can be added to the culture medium
to promote maturation or the scaffold can be functionalized
with multiple bioactive groups to overcome the maturation
problem.
2.1. Use of synthetic scaffolds in combination with soluble
inducers
Nonbioactive synthetic scaffolds can be used in combination
with soluble inducers. These scaffolds combined with soluble
inducers are not actively involved in the differentiation
process; however, they support differentiation by providing a
3D environment for cells that is more similar to their natural
environment when compared to two-dimensional (2D) tissue
culture surfaces. Neurons can have outgrowths in all directions
within 3D scaffolds, thus 3D scaffolds are more accurate rep-
resentations of in vivo tissue architecture, compared to 2D
scaffolds. They provide in vivo-like cell–cell interactions which
increases cellular survival and leads to more realistic gene
expression and cellular behavior. 2D cultures have less com-
patibility with in vivo systems. For example, it has been shown
that dopaminergic neurons isolated from an embryonic brain
display longer viability in 3D systems when compared to
monolayer 2D cultures.14 On the other hand, nutrient depri-
vation in 3D scaffolds causes more severe alterations in the
expression of specific genes, cell proliferation and viability as
well as productivity. Also, it was shown that mechanical inju-
ries cause a more severe response in cells grown in 3D neural
Fig. 2 Bioactive scaffold design for neural differentiation of stem cells.
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cultures than 2D scaffolds even when they are subjected to the
same strain and strain rate.15
These scaffolds do not have bioactive groups and they
usually do not induce differentiation by themselves, except for
when stiffness is used to control differentiation pathway.8–12
Hence, defining an optimal cocktail of soluble inducers such
as growth factors plays an essential role in the success of
differentiation; however, it is costly and complex. Inducers are
often chosen by considering the extracellular signals that play
a role in neural cell survival and differentiation in the central
nervous system. This approach is beneficial in terms of the
ease of material synthesis as the material is not further modi-
fied and it is sufficient that the material does not interfere
with cell survival. However, the lack of bioactivity makes the
use of additional inducers, such as growth factors, inevitable.
The selection of soluble inducers and their concentrations
should be optimized to achieve the differentiation of cells cul-
tured on nonbioactive scaffolds. Several different materials,
mostly polymers, are used for the production of such
scaffolds, examples of which are given below.
Nanofibrous poly-L-lactic acid (PLLA) scaffolds with high
porosity were used for differentiation of neural stem cells
(NSCs) and found to support neurite outgrowth.16 Poly(ethyl-
ene-co-vinyl alcohol) (EVAL) membranes are another type of
polymeric scaffold used for neural cell culture. Rat NSCs cul-
tured on these scaffolds differentiated into neurons and astro-
cytes in the presence of basic fibroblast growth factor (bFGF).
However, polyvinyl alcohol (PVA) scaffolds used in the same
study did not support cell viability.17 Although they do not
contain bioactive signals, such scaffolds provide an initial
environment for cells to produce their own microenvironment.
NSCs encapsulated in a biodegradable polyethylene glycol
(PEG) hydrogel in the presence of bFGF were observed to
produce fibronectin, an indication of the production of a suit-
able microenvironment. These cells later differentiated into
neurons and astrocytes, as demonstrated by immunohisto-
chemistry and western blot analyses. Differentiated neurons
were found to express synaptic protein synaptophysin and they
were responsive to the neurotransmitter GABA (Fig. 3) indicat-
ing the functionality of de novo differentiated neurons.18
Human bone marrow mesenchymal stem cells (MSCs) cultured
on polyesters of 3-hydroxyalkanoate scaffolds in the presence
of neural induction media (serum-free DMEM containing
bFGF, IBMX, INDO and insulin) differentiated into neural cells
with a better efficiency when compared to those grown on
polylactic acid (PLA) scaffolds. In comparison, 3D scaffolds
supported differentiation better than 2D polymer films and
smaller pore sizes resulted in more effective differentiation,
while scaffolds with larger pore sizes lead to a promotion of
proliferation.19 In addition to MSCs, NSCs were also found to
effectively differentiate into neural cells on polyhydroxyalkano-
ates (PHA) with better efficiency when cultured on 3D scaffolds
rather than 2D films of the same polymers. Among the three
different PHA scaffolds used, poly(3-hydroxybutyrate) (PHB),
copolymer of 3-hydroxybutyrate and 4-hydroxybutyrate
(P3HB4HB) and copolymer of 3-hydroxybutyrate and
3-hydroxyhexanoate (PHBHHx), PHBHHx was found to support
neural differentiation of NSCs with better efficiency as demon-
strated by higher levels of β-III tubulin expression by western
blot and immunostaining.20 Microspheres composed of co-
polymers of PHA were also used for neural cell culture. PC-12
cells, primary cortical neurons (CN), and neuronal progenitor
cells (NPC) were cultured on poly(3-hydroxybutyrate-co-3-hydro-
xyvalerate) (PHBV) microspheres along with the soluble growth
factor, BDNF. PHBV microspheres supported the growth and
proliferation of PC-12 cells and the differentiation of NPCs
into neurons. However, the level of maturation of differen-
tiated NPCs was lower when compared to the full maturation
of CNs.21
Another nonbioactive polymeric scaffold for neural regene-
ration was fabricated by ink-jet microdispensing PLA/polyca-
prolactone (PCL) in 80/20 proportions. In this study,
genetically modified human embryonic kidney cells (EcR-293
cells), which can mimic Schwann cells by secreting NGF upon
induction, were utilized. A PLA/PCL scaffold was found to
support cell adhesion and cell growth.22 Another genetically
modified cell line used for neural differentiation was NSCs
which were altered to express TrkC and neurotrophin-3 (NT-3).
These cells differentiated on macroporous poly(lactic-co-glyco-
lic acid) (PLGA) scaffolds without the use of additional soluble
inducers. TrkC and NT-3 expression by NSCs favored neuronal
differentiation over astrocyte and oligodendrocyte
differentiation.23
Polymeric scaffolds fabricated by electrospinning have also
been used for neural differentiation of stem cells. Polyurethane
(PU) scaffolds with high porosity produced by electrospinning
technique were used for the differentiation of human embryo-
nic stem cells (hESCs) into neurons. The hESCs cultured on
PU scaffolds were induced with a neural induction medium
composed of Neuronal A basal medium supplemented with
N2 and B27 supplements along with epidermal growth factor
(EGF) and bFGF. Differentiated cells were positive for β-III
tubulin, an early neural marker, MAP2ab, a mature neuron
marker, and tyrosine hydroxylase (TH), a dopaminergic cell
Fig. 3 Differentiation of NSCs into astrocytes (a) and neurons (b) in PEG hydro-
gels. Expression of nestin by undifferentiated NSCs (c), synaptophysin by differ-
entiated neurons (d) and fibronectin by neural cells (e) are also shown. Scale bar
represents 10 μm (a–d) and 50 μm (e). Reprinted with permission from ref. 18.
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marker. Differentiated cells did not express glial fibrillary
acidic protein (GFAP), indicating neural differentiation in the
absence of astrocytic differentiation. The morphology of the
differentiated cells, as demonstrated by scanning electron
microscopy (SEM) images, also resembled neuronal mor-
phology24 (Fig. 4).
Soluble factors can be used in combination with extracellu-
lar matrix proteins for a more efficient induction of neural
differentiation. Poly(lactic-co-glycolic acid) (PLGA)/poly(L-lactic
acid) (PLLA) polymer scaffolds with pore sizes between
250–500 μm coated with fibronectin or Matrigel™ were used
for neural differentiation of hESC by adding RA into the
growth media. The PLGA/PLLA scaffold provided a biodegrad-
able 3D matrix and fibronectin/Matrigel™ coating which,
along with RA, served as neural differentiation inducers. The
hESCs grown on these scaffolds formed rosette-like structures
with a similar morphology to an embryonic neural tube and
expressed nestin and β-III tubulin. These structures were also
found to express neurofilament (NF) by RNA analysis.25
Encapsulating differentiation inducer proteins in scaffolds
provides sustained release over a long period depending on
the scaffold material. Synthetic materials are commonly used
to entrap neural inducer proteins to provide a gradual release
for supporting neural differentiation. In one study, PLGA con-
duits and NT-3 were combined to generate NT-3-loaded PLGA
carriers and this scaffold was used to co-culture NSCs and
Schwann cells. Sustained release of NT-3 from the scaffold
lasted up to 4 weeks. Immunoreactivity against MAP2 showed
the differentiation of NSCs into neurons. In addition, synaptic
structures and myelin sheaths were detected in the co-culture
by double-immunostaining and electron microscopy analyses.
Synapses between cells were excitable and capable of releasing
synaptic vesicles under depolarization conditions. These
results indicated a positive effect of NT-3 release from PLGA
on the differentiation of NSCs into neurons, the development
of synaptic connections and the myelination of neurites.26
NGF-encapsulating scaffolds are also commonly used in
neural cell culture. A biodegradable electrospun copolymer of
ε-caprolactone and ethyl ethylene phosphate (PCLEEP) with
encapsulated NGF was used for the culture of PC-12 cells. Sus-
tained release of NGF from the scaffold was observed for
3 months, resulting in neurite outgrowth of PC-12 cells.27 Sus-
tained release of NGF from PCL was obtained for 28 days by
using PCL-bovine serum albumin (BSA)-NGF nanofibers that
were also fabricated by electrospinning. The incorporation of
BSA into fibers enhanced the sustained release and homo-
geneous distribution of NGF when compared to PCL fibers
without BSA incorporation.28 Hydrogels of polymers are also
used for sustained release of neural inducers. NGF-loaded
lysine-incorporated poly(2-hydroxyethylmethacrylate) [p(HEMA)]
hydrogels resulted in the slow release of NGF due to the posi-
tive charge of the hydrogel provided by the lysine moieties.
Dorsal root ganglion (DRG) neurons cultured in these hydro-
gels extended much longer neurites when compared to the
soluble NGF-treated cells.29 The p(HEMA) microporous gels
with a gradient of immobilized NGF were used for PC-12
neurite outgrowth assay. In this study, neurites grew in the
direction of higher concentration of NGF in the gradient.30
The sustained release of another neuronal induction factor,
RA, was also obtained by encapsulating RA within aligned PCL
nanofibers. MSC neuronal fate was affected by both nanofiber
topography and controlled RA release. Without RA release,
nanofiber topography was not sufficient to induce synaptophy-
sin expression from MSCs, emphasizing the importance of the
combined effect of topography and sustained release.31
Chemical conjugation of growth factors to electrospun
nanofibers is also effective in inducing neural differentiation,
even more effective than physical adsorption, which leads to
burst release, as shown by Cho et al. In this study, amine-ter-
minated PEG-poly(ε-caprolactone) conjugates were electrospun
to obtain random and aligned nanofibers. NGF was chemically
conjugated to free amine ends of PEG on the surface of the
fibers. MSCs seeded on these NGF-conjugated scaffolds trans-
differentiated into neural cells after 7 days, as evidenced by the
expression of both immature (nestin and β-III tubulin) and
mature (MAP-2) neural markers by RT-PCR and immunostain-
ing analysis. The expression of neural markers was at the
highest level on NGF-conjugated aligned scaffolds when com-
pared to random fibers and NGF-adsorbed fibers.32
2.2. Physical, chemical or biological functionalization of
scaffolds for promotion of neural differentiation
Chemically, physically and biologically functionalized
scaffolds can hold several characteristics of the natural
environment of cells at the same time. Bioactivation can be
achieved through modulating the scaffold by addition of small
chemical groups inspired by specific chemicals found in
different tissues (e.g. phosphate in bone) as well as by present-
ing short peptide sequences on the surface of the scaffold that
are functional domains of inducer proteins. Physical pro-
perties of tissues including elasticity, stiffness, roughness and
electrical conductivity are other important parameters that
should be considered for scaffold functionalization. In this
section, different approaches of scaffold functionalization for
neural cell culture are explained in detail.
Fig. 4 Neural differentiation of hESCs on electrospun PU scaffolds. Differen-
tiated cells express β-III tubulin (a), MAP2ab (b) and TH (c). (d) SEM micrographs
of differentiated cells are demonstrated. Reprinted with permission from ref. 24.
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2.2.1. Modification of scaffold to provide control over sub-
strate stiffness. When designing a scaffold for neural differen-
tiation, the mechanical properties of the scaffold should be
designed to be optimal, near to that of brain tissue, which is
below 1 kPa.33 Cell differentiation caused by tissue elasticity is
proposed to be driven by myosin-II motors and the same
mechanism can be effective for cell responses to scaffold
stiffness.34 Scaffolds produced by using this approach are
beneficial in that they provide similar mechanical signals to
cells as those cultured in their natural environment. The
mechanical stimulation of stem cells by culturing in such a
scaffold can be directed into desired cell fates. However, the
process of producing such scaffolds requires some extra care
in order not to interfere with cell viability. Scaffolds with
adaptable stiffness can be produced by adjusting the level of
crosslinking agents. Most of the crosslinking agents are cyto-
toxic by themselves, so an additional step is required to get rid
of remaining agents after crosslinking of the scaffold to avoid
a cytotoxicity problem.
In a pioneering study, polyacrylamide gels with elasticities
between 0.1–1 kPa were coated with collagen I and used for
the direct induction of neural differentiation of hMSCs
without a requirement for any soluble factor. The hMSCs
obtained a neuronal morphology (Fig. 5) with the expression
of a wide array of neural markers, including commitment
(nestin), early differentiation (β-III tubulin), and mature neural
cell markers (NF and MAP2) as demonstrated by immunofluo-
rescence, western blot and microarray analyses. After three
weeks of culture on these soft substrates, hMSCs committed to
neural cell fate irreversibly even under the influence of myo-
genic and osteogenic inducers.9
Laminin-coated methacrylamide chitosan (MAC) hydrogels
with different stiffness values were also used for analysis of
stem cell behavior with respect to changing stiffness. The pro-
liferation and differentiation of NSCs were found to be
promoted on the softest scaffolds with elasticities less than
1 kPa (Fig. 6).10 MAC hydrogels with a similar stiffness to brain
tissue were also functionalized by IFN-γ and resulted in neural
differentiation of NSCs more effectively than brain-derived
neurotrophic factor (BDNF)-treated NSCs.35 Polydimethylsil-
oxane (PDMS) substrates with differing stiffness produced by
using varying proportions of cross-linking agents were also
used for NSC culture. In this study, astrocyte differentiation
occurred at the highest level on soft substrates while oligo-
dendrocyte differentiation rate (induced by addition of thyroid
hormone) was found to be independent of substrate stiffness.
The number of differentiated neurons was also observed to be
independent of stiffness, while maturation of these differen-
tiated neurons was highly dependent on the degree of
stiffness. Neurite length and expression of synaptic proteins
were promoted on scaffolds with stiffness values near to that
of brain tissue (Fig. 7).12
2.2.2. Electrically conductive scaffolds. Since neurons are
electrically excitable cells, electrical conductivity is an impor-
tant physical property to enhance neural cell activity.36 Provid-
ing electrical conductivity allows electrical stimulation of the
cells cultured within these scaffolds and this might be useful
in terms of eliciting action potential by cells and improving
synaptic connections. Electrical conductivity can be incorpor-
ated into synthetic scaffolds by using conductive materials
during synthesis. Aligned nanofiber scaffolds formed by elec-
trospun PLLA blended with carbon nanotubes (CNT) were con-
structed for this purpose. Both the conductivity of CNT and
the alignment of the fibers were found to promote neural
differentiation of mouse embryonic stem cells as shown by a
higher expression of mature neuronal markers MAP-2 and
neuron specific enolase (NSE).37 Electrically active electrospun
fibers were also produced from blends of poly(lactide-co-ε-
caprolactone) (PLCL) and a conductive polymer, polyaniline
Fig. 5 Neural differentiation of hMSCs on soft polyacrylamide gel scaffolds.
(a) Change in cell morphology when cultured on the substrate with low
stiffness. Note the neural projection-like branches. (b) Expression of neural
markers β-III tubulin and NF by differentiated cells. (c) Western blot analysis of
neural markers for cells grown on PA gels with different elasticities. Glass (GL)
surface was used as control. Reprinted with permission from ref. 9.
Fig. 6 Differentiation of NSCs in neurobasal media on soft MAC hydrogel of
<1 kPa substrate stiffness over 8 days of culture. Reprinted with permission from
ref. 10.
Fig. 7 Differentiation of NSCs into neurons on tissue culture plate (a) and
PDMS substrates with changing stiffness; 750 kPa (b) and 12 kPa (c). Reprinted
with permission from ref. 12.
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(PAni). PC-12 cells were cultured on these electrically active
fibers and their viability, differentiation, and morphologies of
neurite extensions were analyzed. The PLCL-PAni blends
enhanced NGF-induced neurite outgrowth by PC-12 cells.
Growth-associated protein 43 (GAP-43) and β-III tubulin
expressions were also found to be higher in cells cultured on
these nanofibers.38
In another study, glass surfaces coated with the electroac-
tive silsesquioxane precursor N-(4-aminophenyl)-N′-(4′-(3-
triethoxysilyl-propyl-ureido) phenyl-1,4-quinonenediimine)
(ATQD) were covalently modified with cyclic RGD peptide.
PC-12 cells were reported to extend neurites on these surfaces
even in the absence of NGF. Addition of NGF further enhanced
the level of neurite extension (Fig. 8).39
2.2.3. Effect of substrate topography. Surface geometry,
topography and alignment are other physical parameters that
affect neural differentiation. Modifying surfaces with a certain
geometry or topography or providing alignment in the surface
enhances cell orientation and improves the polarity, which is
important in neural cell development. Besides, orienting
themselves on the scaffold, neurons can also orient their neu-
rites in the direction of alignments on the surface. Such an
alignment is especially beneficial when considering such
materials for regeneration of peripheral nerves whose align-
ments are naturally guided by Schwann cells. Aligned nano-
fiber substrates with immobilized signal proteins are found to
induce neurite extension in several studies.
Aligned PLLA nanofibers produced by electrospinning tech-
nique modified by bFGF and laminin immobilization via
heparin interaction could efficiently induce neurite extension
from DRG. Neurites of DRG cells were extended in the direc-
tion of alignment, which has considerable importance for
nerve bridging in clinical applications (Fig. 9).40 Aligned PLCL
nanofibers also induced DRG neurite alignment through the
direction of fibers and coating PLCL fibers with multi-walled
carbon nanotubes was found to lead to extension of much
longer neurites. CNTs used in this study were ionically modi-
fied. This coating increased the hydrophilicity of the PLCL
fibers, which was attributed to longer neurite production. In
addition, the CNT coating provided electrical conductivity to
the non-conducting PLCL fibers, making the environment
more suitable for neural cells.41 Much longer neurites were
produced by PC-12 cells cultured on CNT-coated PLCL nano-
fibers compared to the uncoated PLCL fibers, similar to the
response of DRG cells.42
Embryonic stem cells (ESCs) seeded on aligned electrospun
PCL fibers exhibited neurite growth in the same direction as
the alignment, similar to DRG cells on PLLA and PLCL fibers,
after retinoic acid treatment (Fig. 10). In addition, the number
of differentiated astrocytes was less on aligned PCL fibers com-
pared to cells cultured on random PCL fibers.43 Nanoscale
ridge-groove patterns of polyurethane acrylate (PUA) fabricated
by UV-assisted capillary force lithography were also used to
direct selective neural differentiation of ESCs without the use
of any soluble inducers. ESCs seeded on aligned PUA sub-
strates differentiated into neural cells that express neural
markers Tuj1, HuC/D and MAP2, but not GFAP, indicating the
absence of astrocytes. Cells cultured on flat PUA surfaces
didn’t express any of these neural markers. Some of the cells
on the ridge-groove patterns even differentiated into serotoner-
gic and GABAergic neurons as demonstrated by the expression
of serotonin and GABA.44
Aligned electrospun nanofibers were also used for NSC
differentiation. The direction of NSC elongation and neurite
outgrowth was found to be parallel to the direction of PLLA
fibers for aligned scaffolds (Fig. 11). Also, the rate of NSC
differentiation was higher for PLLA nanofibers than that for
microfibers, indicating that the aligned nanofibrous PLLA
scaffold could have more potential use in neural tissue engi-
neering than microscale aligned fibers.45 Effects of PLLA nano-
fibers might vary with respect to different properties of these
fibers such as fiber diameter or density. For example, when
DRG cells were cultured on highly aligned PLLA electrospun
fibers, the direction and extent of neurite extension and
Schwann cell migration from DRG explants was found to be
influenced significantly by fiber diameter. The length of neu-
rites was shorter on small diameter fibers (293 nm) when
Fig. 9 Neurite outgrowth from DRG cells on PLLA nanofibers demonstrated by
neurofilament staining. DRG cells on (A) random nanofibers, (B) aligned
nanofibers, and (C) aligned nanofibers immobilized with bFGF. Reprinted with
permission from ref. 40.
Fig. 8 Neurite extension of PC-12 cells on electroactive surfaces. Tissue culture
plate without (a), and with NGF (b), electroactive ATQD-RGD without (c) and
with NGF (d) (50 ng mL−1). Reprinted with permission from ref. 39.
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compared to the large diameter ones (1325 nm).46 In another
study, increasing the PLLA fiber density was found to be corr-
elated to an increase in neurite density, without affecting the
length of the extending neurites (Fig. 12).47 The effect of topo-
graphy on NSC differentiation has also been demonstrated
with several other polymeric fibers as scaffolds. NSCs cultured
on aligned poly(ε-caprolactone)/gelatin scaffolds exhibited
neurite outgrowth parallel to the fiber direction. In this study,
gelatin was found to further promote differentiation in
addition to scaffold alignment.48
Neuritogenesis and major neurite (axon) formation was
demonstrated to be accelerated in primary motor neurons cul-
tured on electrospun PLLA nanofibers (0.6–0.8 μm diameter)
when compared to PLLA films and glass substrates. However,
there was no difference between random and aligned fibers in
the acceleration of neurite formation, and the minor neurite
density and neurites were shorter in cells grown on fibers.49
Besides the aligned polymeric fibers, nanogratings were
also used to produce aligned surfaces for stem cell
differentiation. Aligned PDMS nanogratings lead to neural
differentiation of hMSCs, even in the absence of any soluble
factor, as evidenced by upregulation of the neural markers
nestin, β-III tubulin, MAP2 and synaptophysin. Cells seeded on
flat PDMS showed significantly lower expression of these
neural markers, while the addition of retinoic acid increased
their expression levels. Also, nanogratings were found to
induce neural differentiation better than micropatterned
PDMS substrates.50 Micropatterned PDMS surfaces coated with
poly-L-lysine (PLL) and laminin can also serve as effective
neurite guidance surfaces for NSCs but the channel width
should be properly defined for proper alignment and adequate
neuron density. Smaller micropatterns were found to provide a
perfect alignment, but hindered neurite development. On the
other hand, larger micropatterns provided higher neuron
density but neurites escaped out of the microchannel.51 Pre-
cisely-sized micropatterned poly(methyl methacrylate) (PMMA)
grooved scaffolds were used for mature astrocyte differen-
tiation from radial glia-like cells (RGLC) in vitro without
adding any soluble or substrate-adsorbed biochemical factors.
RGLC were highly organized and the cells aligned along a
2 μm-patterned PMMA line. They expressed both nestin and
Pax6, and generated different intermediate progenitors. These
micropatterned surfaces also supported and directed axonal
growth and neuronal migration.52
Surface topography also affects the resting membrane
potential and voltage-gated calcium channel responsiveness,
which are important parameters in the determination of the
functionality of a differentiated neural cell. Neural progenitor
cells grown on polystyrene microbead arrayed substrates
exerted more negative resting membrane potentials and higher
voltage-gated calcium channel responsiveness when compared
to cells grown on flat polystyrene surfaces, indicating that
surface roughness can direct the differentiation of stem cells
into more functional neural cells.53
Besides topography, surface geometry was also found to
have profound effects on cellular behaviors including
adhesion, proliferation and differentiation. Poly(ε-capro-
lactone) nanowires fabricated by a solvent free nanoscale tem-
plate technique were found to support PC-12 cell adhesion,
proliferation and viability better when compared to smooth
PCL surfaces. Cells were found to interact with PCL nanowires
via their lamellopodia and filopodia, as evidenced by SEM
imaging. Neural differentiation was evidenced by the presence
of neurite extensions as well as NF and TH expression evi-
denced by immunofluorescence analysis, while neurite exten-
sion was not observed on a smooth PCL surface.54
Fig. 10 Neural differentiation of ESCs on random (a,b) and aligned (c,d) PCL fibers. Immunohistochemistry is performed for a neural cell marker, Tuj1. Reprinted
with permission from ref. 43.
Fig. 11 SEM images of NSCs differentiated on aligned nanofibers (a),
microfibers (b) and random nanofibers (c) of PCL. Arrows indicate sites of inter-
action between cells and the scaffold. Reprinted with permission from ref. 45.
Fig. 12 Effect of fiber density on the number of neurites produced by DRG
cells cultured on a. low density, and b. high density aligned electrospun PLLA
scaffolds for five days. Immunohistochemistry is performed for neurofilament.
Reproduced with permission from ref. 47.
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2.2.4. Chemical modifications of the scaffolds. The incor-
poration of specific chemical groups into scaffolds in order to
mimic the abundance of some chemical moieties in the extra-
cellular environment is another important modification for
neural differentiation. Inspired by the abundance of certain
chemical groups in specific tissues, substrates can be functio-
nalized for the induction of NSC differentiation. Glass surfaces
activated by hydroxyl (–OH), sulfonic (–SO3H), amino (–NH2),
carboxyl (–COOH), mercapto (–SH) and methyl (–CH3) groups
were used for NSC culture to deduce if any of these groups
leads differentiation into a specific neural cell subtype. –SO3H
functionalized surfaces induced more oligodendrocytic differ-
entiation, while NSCs grown on –COOH functionalized sur-
faces were more prone to differentiate into astrocytes.
Neuronal differentiation could take place only on amino-func-
tionalized surfaces, however, the differentiation efficiency was
low (Fig. 13).55
Another method of functionalizing polymeric scaffolds is
through mimicking the chemical structure of key proteins in
neural differentiation. Acetylcholine-like polymers were syn-
thesized by click chemistry and free radical polymerization
from a bioactive unit mimicking acetylcholine, dimethylamino-
methyl methacrylate (DMAEMA) and a bioinert unit, poly-
(ethylene glycol) monomethyl ether-glycidyl methacrylate
(MePEG-GMA). Polymeric surfaces consisting of 1 : 60
(mol/mol) of MePEG-GMA to DMAEMA were found to support
adhesion, normal morphology and neuronal outgrowth of
hippocampal neurons effectively.56
The introduction of specific chemical groups on polymeric
scaffolds can also be used for modification of surface tension,
which in turn was found to affect neurite outgrowth. Embryo-
nic cortical neurons that were cultured on electrospun PLLA
and PLGA fibers treated with KOH to change surface tension
grew longer neurites on the surfaces with the lowest tension,
which were also the most hydrophobic scaffolds used in the
study.57 Chemical heterogeneity of the surface, which leads to
surface disorder and the formation of local gradients in the
surface free-energy, is another parameter that was found to
have a role in neuritogenesis. PC-12 cells seeded on a self-
assembled monolayer of alkylsiloxanes, which were highly dis-
ordered with high levels of chemical heterogeneity, could
extend neurites within 48 h even without NGF treatment.58
Fig. 13 Differentiation of NSCs on chemically functionalized glass substrates as demonstrated by expression of markers for astrocytes (GFAP), neurons (β-III tubulin)
and oligodendrocytes (O4). Undifferentiated NSCs are shown by nestin expression. Reprinted with permission from ref. 55.
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2.2.5. ECM proteins for scaffold biofunctionalization.
Extracellular matrix proteins that are known to affect neural
cell adhesion and differentiation can also be used for modifi-
cation of scaffolds to incorporate bioactivity. As these proteins
are active role players in the differentiation of cells in their
native environment, their use in scaffolds is quite advan-
tageous in terms of improving differentiation efficiency.
However, since these proteins are isolated from animals, their
use in scaffolds limits their clinical use.
In order to find an optimal combination of inducer mole-
cules and biomaterials for NSC differentiation, a combinatorial
protein display was carried out to screen mixtures of a variety
of biomaterials with different soluble signals. Natural and syn-
thetic matrices (fibronectin (FN), laminin (LN), PLL, RGD,
IKVAV, PEI; poly(ethyleneimine)) containing different growth
factors (EGF, NGF, CNTF, NT-3) were immobilized onto gold
surfaces by photo-assisted patterning of an alkanethiol self-
assembled monolayer as spots. NSCs were grown on these
spots, each with different combinations of matrices and
growth factors, and their differentiation was analyzed by
immunohistochemistry. This study revealed FN/CNTF and
RGD/CNTF to be the most efficient inducers of astroglial
differentiation and LN/NGF, FN/NGF, RGD/NGF, FN/NT-3 and
RGD/NT-3 as the most effective neuronal differentiation indu-
cers among the studied combinations.59
In another study, methylcellulose (MC) scaffolds functio-
nalized with laminin-1 (MC-x-LN1) were used for culturing
primary murine neurospheres. MC-x-LN1 was found to
enhance both NSC survival and maturation. In addition, lower
levels of apoptotic activity were observed on MC-x-LN1 when
compared to unmodified MC controls. The expression of
neuronal and oligodendrocyte precursor markers showed a
higher differentiation level on laminin-functionalized scaffolds
when compared to cells on unmodified MC surfaces.60
Aerogels are also an important class of materials with
tunable chemical, physical, and surface properties. Polyurea
crosslinked silica aerogels (PCSA) were coated with PLL, base-
ment membrane extract (BME), or laminin-1 and used for a
culture of DRG neurons. Interactions of DRG neurons were
tracked on PCSA and PLL, BME, and laminin-coated aerogels.
In this study, laminin was found to be the most effective
surface treatment for the attachment and growth of DRG
neurons on the PCSA surface.61
Polymeric scaffolds can also be functionalized by producing
fibers of a mixture of a polymer and an ECM protein by electro-
spinning technique. Electrospun blended PLLA/laminin
fibers promoted neural differentiation of PC-12 cells in the
presence of NGF significantly more efficiently than the
unblended PLLA nanofibers.62 PLCL/collagen fibrous scaffolds
fabricated by electrospinning were used for neural differen-
tiation of MSCs. Neural induction was performed gradually,
first culturing MSCs in pretreatment media composed of
β-mercaptoethanol, EGF, and bFGF; and then in the neural
induction media consisting of N2 supplement, β-mercap-
toethanol, insulin, EGF, NGF, and BDNF. MSCs on PCL/col-
lagen fibers gained a neuronal phenotype with multipolar
elongations along with the expression of neural markers NF
and nestin (Fig. 14).63
2.2.6. ECM-derived short peptides for scaffold biofunctio-
nalization. The presentation of short peptides that are func-
tional domains of signal proteins on the scaffold surface is
another approach for the induction of neural differentiation.
This approach provides the differentiation-inducing properties
of ECM proteins as these scaffolds present peptides that inter-
act with cell surface receptors similarly to native ECM proteins.
Besides, it also holds the advantage of producing completely
synthetic yet bioactive scaffolds without the risk of pathogenic
contaminations caused by the use of animal-derived proteins.
In such a study, functional domains of ECM proteins were
produced as a fusion protein to the Escherichia coli outer mem-
brane protein, OmpA, and attached to gold-coated surfaces.
These bioactive surfaces effectively induced neurite extension
and branching of neurites in PC-12 cells, as well as differen-
tiation of NSCs.64 Differentiation of fetal NSCs was promoted
on superporous p(HEMA-AEMA) hydrogels modified with
laminin-derived IKVAV, when compared to unmodified
p(HEMA-AEMA). NSCs cultured on IKVAV-p(HEMA-AEMA)
scaffolds expressed higher levels of β-III tubulin, NF and synap-
tophysin.65 Polyamide electrospun nanofibers covalently
attached to neuroactive tenascin C-derived peptides were
found to promote neuritogenesis and neurite extension in
primary neurons isolated from several different regions of
brain, when compared to those cultured on unmodified poly-
amide scaffolds and PLL-coated glass cover slips.66
In another study, poly(HEMA-co-AEMA) nerve guidance
channels were produced by a fiber templating technique and
modified with laminin-derived peptides (YIGSR and IKVAV).
Primary chick DRG cells cultured in these channels could
effectively extend neurites. There was no statistical difference
Fig. 14 Neural differentiation of MSCs on PLCL/collagen scaffolds. SEM images
of differentiated (a) and undifferentiated (b) MSCs. Neurofilament (green) and
nestin (red) expressions of differentiated MSCs are shown in (c) and (d) respect-
ively. Reprinted with permission from ref. 63.
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in terms of neurite length between the cells in these channels
and those on a PLL/laminin positive control surface, indicat-
ing that laminin-derived epitopes are as efficient as laminin
itself in the induction of neurite outgrowth.67
Self-assembled peptide scaffold systems contain functional
domains found in ECM proteins or other neural differentiation
inducer proteins, which bind to cell surface receptors. Peptide
amphiphile (PA) nanofibers with cell specific signals can be
produced by synthesis of the epitope of a signal protein and
linking this peptide to an alkyl tail along with hydrophobic
amino acids. PA molecules form nanofibers in aqueous solu-
tions by self-assembly through charge neutralization and
hydrogen bonding. These nanofibers present epitopes on their
surface, directly available to cell surface receptors. PA nano-
fibers with laminin epitope (IKVAV) were found to induce selec-
tive differentiation of neural progenitor cells into neurons
while suppressing astrocyte differentiation.68 PA nanofibers
can present multiple epitopes at the same time. PA nanofibers,
formed from laminin-derived IKVAV-PAs along with growth
factor affine heparan sulfate-mimicking PAs, stimulated PC-12
differentiation cooperatively. Neurite outgrowth was promoted
when cells were cultured on scaffolds presenting both func-
tional groups. In addition, cells were found to extend neurites
on these scaffolds even in the presence of inhibitory chondroi-
tin sulfate proteoglycans.69 Heparan sulfate-mimicking PAs
were found to have affinity towards NGF, providing an increase
in the local concentration of NGF in close vicinity of cells.
More importantly, NGF does not lose its bioactivity after inter-
action with these PA nanofibers, which was evident from its
inductive effect on neurite outgrowth (Fig. 15).70
The PA nanofibers were also used in a spinal cord injury
(SCI) model in mice. IKVAV-PA injection led to a reduction in
astrogliosis and cell death while increasing the number of
oligodendroglia at the site of injury. IKVAV peptide alone was
not able to promote recovery, which showed that both the
nanofiber structure of the PA and the IKVAV sequence were
required.71 The anatomical basis of the behavioural recovery
coming from the injection of IKVAV-PA was analyzed in a separ-
ate study and the major factor for this improvement was found
to be the increased density of serotonergic fibers close to the
lesion.72
The mechanical properties of PA nanofiber scaffolds can
also be modified by using different proportions of signal
incorporated PAs and non-bioactive but mechanically more
stable molecules. Such an approach leads to the formation of
more stable and stiffer gels.73 In addition, their gelation kine-
tics can be modified by changing the amino acid sequences
that are important for structural properties of the fibers. By
including more hydrophilic and bulky amino acids, gelation
can be slowed down without disrupting bioactivity, which can
be important for in vivo applications such as injections.74
The PA gels can also be used for efficient delivery of biologi-
cal molecules to the treatment site. One such example is the
delivery of Sonic hedgehog (SHH) via monodomain gels con-
taining aligned PA nanofibers. SHH protein has important
roles in peripheral nerve regeneration. SHH signalling was
inhibited in rats and their cavernous nerve was crushed
leading peripheral nerve damage to form the animal model in
this study. SHH was then delivered to the crushed cavernous
nerve by the PA gel and promoted regeneration, suppressed
penile apoptosis and improved erectile function. Such a treat-
ment might be crucial in regeneration of the cavernous nerve
in prostatectomy and diabetic patients where SHH levels are
decreased.75 A hybrid matrix approach with the combination
of type I collagen and peptide amphiphile nanofibers was also
shown to support neuronal survival, morphogenesis, and fine
control over dendrite and axon growth of Purkinje cells (PC).
While collagen provided a favorable mechanical support, the
laminin epitope concentration was adjusted to control the
matrix bioactivity by using PAs. Therefore, this system enabled
the adjustment of laminin epitope density to control bioacti-
vity without affecting its structural integrity.76
Self-assembled peptide nanofibers produced from alternat-
ing basic, hydrophobic and acidic amino acids (e.g., RADA16)
are also used for neural cell culture. They were initially
reported to support the adhesion, neurite extension and
synapse formation of PC-12 cells as well as primary neural
cells.77 These scaffolds better enhanced neural differentiation
when they were functionalized with epitopes of ECM proteins
(laminin, collagen, and fibronectin) and bone marrow homing
peptides (BMHP1, and BMHP2).78 RADA scaffolds were also
synthesized by incorporating an FGL motif, a synthetic FGF
receptor derived from a neural cell adhesion molecule
(NCAM). DRG neurons cultured on these scaffolds extended
much longer neurites when compared to bare (RADA)16
scaffolds, and the number of cells extending the neurites was
higher in FGL-incorporated scaffolds.79 When (RADA)16
scaffolds were mixed with laminin for biofunctionalization,
NSC differentiation was enhanced in 3D culture.80 (RADA)16-I
scaffolds were also successful in axonal regeneration of an
in vivo acute optic tract injury, and provided visual recovery.81
Peptide nanofibers can also be used as delivery vehicles for
the sustained delivery of cytokines. (RADA)16 scaffolds modi-
fied by the addition of negatively or positively charged amino
acids were used for sustained delivery of vascular endothelial
growth factor, bFGF, and BDNF. Positively charged growth
factors could be released more readily from positively charged
scaffolds, while they were released slowly from negatively
charged scaffolds.82 Glycine spacers were shown to increase
Fig. 15 Immunostaining of PC-12 cells against β-III tubulin (a) and Syn1 (b) on
NGF-treated heparan sulfate-mimicking nanofibers. Panel (c) shows merged
images of β-III tubulin and Syn1 on the same cells. Reprinted with permission
from ref. 70.
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both the stability and functional motif exposure of the nanofi-
bers. Nanofibers with more glycine residues incorporated
between the self-assembling sequence (RADA)16-I and the bio-
active sequence (PFSSTKT, derived from BMHP1) supported
NSCs adhesion, proliferation and differentiation more effec-
tively than those with shorter spacers.83
Short peptide epitopes derived from ECM components were
also used to produce peptide-modified silica thin gels for
neural differentiation induction. Embryonic carcinoma stem
cells were cultured on laminin-derived YIGSR, fibronectin-
derived RGD and tenascin-derived NID peptide-modified sur-
faces in the presence of retinoic acid. RGD/YIGSR-modified
substrates induced longer neurite formation, while the RGD/
YIGSR/NID substrate resulted in an increased number of neu-
rites per field.84
Mussel adhesive protein-inspired immobilization strategies
are also useful in the attachment of bioactive signals to
organic and inorganic materials for the modification of
scaffolds. Growth factors and adhesion peptides containing
amine and thiol groups were immobilized onto the polydop-
amine (PD)-coated polymer substrates for NSCs differentiation.
ECM protein-derived adhesion peptides (fibronectin [RGD]
and laminin [YIGSR]) and neurotrophic factors (NGF and glial
cell line-derived neurotrophic (GDNF)) were immobilized by
using this strategy. These scaffolds promoted differentiation
and proliferation of human fetal brain-derived NSCs and
human induced pluripotent stem cell-derived NSCs. Enhance-
ment of neuronal differentiation of human fetal NSCs in
PS-PD substrates was revealed by immunostaining and
qRT-PCR analyses of Tuj1. Immunostaining and qRT-PCR of
astrocyte marker GFAP demonstrated that immobilization of
GDNF, C(K)GGYIGSR, and KGGRGD enhanced glial differen-
tiation (astrocyte lineage) of human NSCs on the PS-PD
substrates.85
Nanofiber-like viruses can also be used for the presentation
of cell surface receptor binding epitopes on the scaffold
surface. M13 phages were genetically engineered to express
IKVAV and RGD peptides as their coat proteins at high density
and they were drop-cast in order to produce aligned nano-
fibrous scaffolds. NSCs could easily differentiate into neurons
on these viral scaffolds and produced neurites in the same
direction as the alignment of the viral nanofibers.86
3. Identification methods for de novo
differentiated neurons
The methods used in the evaluation of the effect of culture
conditions (i.e. scaffold or medium components) are critical
for the assessment of the effectiveness of the biomaterials.
Analyses of already differentiated neurons or differentiation of
neural progenitor cells are simpler due to the limited cell fates
and end with more reliable results, however, analysis of the
differentiation of stem cells from other tissues requires more
effort. Use of more than one method should be preferred in
order to avoid unreliable results. For instance, although the
distinct morphology of neural cells is useful to get an idea
about the identity of the differentiated cell, it might be mis-
leading if used alone. Cellular toxicity is known to cause cell
body shrinkage along with some extensions that might be con-
fusing due to its resemblance to neural cell morphology.87
Hence, morphological observations should be supported with
the expression of lineage-specific genes and functional tests to
verify that the differentiated cell is able to conduct action
potentials. Several methods are used for the analysis of
different aspects of neural differentiation. Morphological
observations are mainly based on optical microscopy images
that are useful in terms of neurite outgrowth analysis. A variety
of softwares are available for neurite outgrowth-based measure-
ments from optical microscopy images. Among these softwares,
Image J is the most commonly used one. To evaluate the effect
of scaffolds on neurite outgrowth, the total length of neurites
per image,12,28,29,39–43,45–47,49,51,56,57,62,64,66,67,69,70,76,77,79,83,86
mean number of neurites extended by a single cell,38,49,58,64
number of branches in a specified area,64 and percentage of
cells extending neurites27,28,30,38,49,60,66,69,79 are commonly
measured by using Image J. The imaging of cells with electron
microscopy is also useful in morphological analysis of differen-
tiated cells as it provides more detailed images at higher
magnifications. Growth cone morphology and the morphology
of the extended neurites can be easily observed in SEM
images.16,19,20,24,39,45,48,53,54,61–63,69,78,86 Morphology of synapses
can be analyzed in fine detail by transmission electron
microscopy imaging.26
Since morphological observations alone are not sufficient
to define the differentiation status, they can be supported with
molecular information such as the expression of marker
genes. There are various lineage-specific marker genes defined
for neural progenitor cells, neurons, astrocytes and oligo-
dendrocytes, and some of these even specify the subtypes of
neurons.88 Table 3 gives a list of the most commonly used
marker genes and analysis methods. Expression of these genes
can be analyzed both at the RNA level (by microarray and
RT-PCR methods) and protein level (by western blot, immuno-
staining and ELISA methods). It is important to check protein
levels, even if mRNA levels rise indicating differentiation.
mRNA levels, although informative, might be misleading in
some cases where gene expression levels at the transcriptional
and translational levels differ.89,90
By using morphological observations along with expression
analysis of various marker genes, a differentiated cell’s identity
can be defined. However, in order to verify whether a neuron is
capable of conducting action potentials and making synapses
like its natural counterparts, additional tests are required to
verify its functionality. Electrophysiological recordings of
single cells by patch clamp is quite useful for such an ana-
lysis.76 Commercially available calcium-binding dyes can also
be used to analyze stimulation based on calcium ion flux in
differentiated neurons. Stimulation by neurotransmitters or
high extracellular K+ ion concentrations leading to depolariz-
ation results in an increase in the intracellular calcium ion
levels. Fluorescence upon binding of intracellular calcium to
Review Biomaterials Science




































Table 1 Synthetic materials used as substrates for neural cell culture and differentiation
Substrate Cells used Ref.
Acetylcholine-like polymers Hippocampal neurons 56
Glass PC-12, NSC 39, 55
Gold PC-12, NSC 64
M13 phages (nanofiber-like viruses) NSC 86
Methacrylamide chitosan hydrogels NSC 10, 35
Methylcellulose Primary murine neurospheres 60
Peptide amphiphile nanofibers Neural progenitor cells, PC-12, Purkinje cells 68–76
Peptide nanofibers (RADA16) PC-12, NSC, DRG 77–83
Polyacrylamide gels MSC 9
Polyamide nanofibers Primary neurons from brain 66
Polycaprolactone (PCL) fibers ESC, MSC, EcR-293 cells 22, 31, 43
Polydimethylsiloxane (PDMS) NSC, MSC 12, 50, 51
Poly(ethylene-co-vinyl alcohol) NSC 17
Polyethylene glycol (PEG) NSC 18, 56
Polyhydroxyalkanoates (PHA) MSC, NSC 19, 21
Poly(lactic-co-glycolic acid) (PLGA) fibers NSC, ESC, cortical neurons 23, 25, 26, 57
Poly(lactide-co-ε-caprolactone) (PLCL) PC-12, DRG, MSC 38, 41, 42, 63
Poly-L-lactic acid (PLLA) ESC, MSC, NSC, DRG, cortical neurons 16, 25, 37, 38, 40–42, 45, 46, 57, 63
Polydopamine substrate NSC 85
Poly(methyl methacrylate) (PMMA) Radial glia-like cells 52
Poly(2-hydroxyethylmethacrylate) (p(HEMA)) DRG cells, PC-12, NSC 37, 65, 67
Polyurea cross-linked silica aerogels DRG 61
Polyurethane scaffolds ESC 24, 29, 44, 61
Poly(ε-caprolactone) PC-12, MSC, NSC 27, 28, 32, 48
Silica thin gels Embryonic carcinoma cells 84
Table 2 Functionalization of synthetic substrates for improved neural cell culture and differentiation
Substrate Functionalization Cells used Result Ref.
Modification for providing control over substrate stiffness
Polyacrylamide gels Stiffness in 0.1–1 kPa range, coating with
collagen I





Stiffness modification and coating with
laminin
NSC Proliferation and differentiation is






NSC Neural differentiation 35
PDMS Stiffness modification NSC Differentiation into astrocytes and
maturation of differentiated neurons
highest on softest substrates
12
Providing electrical conductivity by modifications
PLLA Electrospinning blending with carbon
nanotubes
ESC Neural differentiation is promoted 37
PLCL Electrospinning blending with PAni PC-12 Neurite outgrowth is enhanced 38
Glass Silsesquioxane precursor ATQD covalently
attached to RGD peptide
PC-12 Neurite outgrowth even in the absence of
NGF
39
Providing alignment in substrate
PLLA fibers Aligned fibers NSC, DRG NSC differentiation. Neurite extension in
the direction of alignment, both for NSCs
and DRGs
45, 46
Aligned fibers modified with bFGF and
laminin immobilization by heparin
interaction
DRG Neurite extension in the direction of
alignment
40
PLCL nanofibers Aligned fibers coated with carbon
nanotubes
DRG Longer neurites growing in the direction of
alignment
41
PCL fibers Aligned fibers ESC After RA treatment, lower number of
astrocytes on aligned fibers along with
neurite extension in the direction of
alignment
43
Polyurethane acrylate Nanoscale ridge-groove patterns ESC Selective neural differentiation even in the
absence of any soluble factor
44
Poly(ε-caprolactone) Aligned fibers produced by
electrospinning blending with gelatin
NSC Differentiation is promoted, neurite
extension in the direction of alignment
48
PDMS Aligned nanogratings MSC Upregulation of neural markers 50
Aligned channels by micropatterning and
coating with poly-L-lysine and laminin








































the dye can be imaged with confocal microscopy in a time
series to obtain a plot of calcium spikes over time.18,53 Another
fluorescent imaging method developed as a functionality test
for neurons is based on the release of synaptic vesicles
upon depolarization of the cell membrane by high extra-
cellular K+ ion concentrations. A fluorescent dye, (N-3-
Table 2 (Contd.)
Substrate Functionalization Cells used Result Ref.
PMMA Microgrooved patterns Radial glia-like cells Cell alignment along with directed axonal
growth
52
PA nanofibers Aligned PA nanofibers releasing SHH In vivo study for
cavernous nerve
regeneration
Cavernous nerve regeneration, suppression




Glass Introduction of chemical groups; –OH,
–SO3H, –NH2, –SH, –COOH, –CH3
NSCs Differentiation to oligodendrocytes on
–SO3H-modified surface, astrocytes on










Cells adhere, preserve normal morphology
and extend neurites
56
PLLA or PLGA fibers Modification of surface tension by KOH
treatment
Cortical neurons Longer neurites on surfaces with lowest
tension
57
Use of ECM proteins for biofunctionalization
Methylcellulose Laminin-1 functionalization Primary murine
neurospheres
NSC survival and maturation 60
PLLA fibers PLLA/laminin fibers produced by
electrospinning blending
PC-12 Neural differentiation is enhanced 62
PLCL PLCL/collagen fibers produced by
electrospinning blending












Mixing with laminin NSC Differentiation is improved in 3D culture 80
Use of ECM-derived short peptides for biofunctionalization
Gold ECM proteins fused to E. coli outer
membrane protein







Selective differentiation into neurons,
suppression of astrocyte differentiation
68
PA nanofibers IKVAV incorporation In vivo study for SCI
treatment
Reduction in astrogliosis and cell death,
increase in oligodendroglia cell number at
injury site
71, 72
PA nanofibers Heparan sulfate-mimicking epitope
incorporation
PC-12 Neurite outgrowth provided by NGF affinity
of nanofibers
70
PA nanofibers IKVAV incorporation along with heparan
sulfate-mimicking epitopes
PC-12 Neurite outgrowth is promoted by
cooperative effect of the two epitopes
69
PA nanofibers Mixing collagen I with PAs carrying
laminin-derived epitopes to produce a
hybrid matrix
Purkinje cells Improved mechanical support and
adjustment of laminin epitope density is





Epitopes derived from laminin, collagen,
fibronectin and bone marrow homing
peptides are incorporated
NSC Neural differentiation is enhanced 78
Peptide nanofibers
(RADA16)
FGL motif (a synthetic FGF receptor
derived from NCAM) is incorporated
DRG Higher percentage of cells extend neurites
and neurites are much longer
79





Longer neurite outgrowth on RGD/YIGSR,
increased number of neurites on RGD/
YIGSR/NID
84
PS Immobilization of fibronectin (RGD),
laminin (YIGSR)-derived peptides and
NGF, GDNF on polydopamine-coated PS




Genetic engineering for expression of
IKVAV and RGD epitopes on phage
surface
NSC Neural differentiation and outgrowth of
neurites in the same direction of phage
alignment
86








Modified with laminin-derived peptides
(YIGSR and IKVAV)








































Table 3 Lineage-specific markers for identification of nervous system cells
Marker Function Ref. Methods used for analysis of expression
NSC markers





cell identity and neural
fate
92, 93 Western blot52
RT-PCR10
Neuron markers
β-III tubulin Microtubule protein
specifically expressed in


































protein found in mature
neurons. Recently
identified as Fox3 gene
product acting as tissue
specific splicing factor
100–102 Immunostaining76


































Intermediate filament 108 Immunostaining10,12,17,18,20,21,23,24,26,31,35,43,44,50–52,55,59,60,68,78,83,85
Western blot18,26,52
RT-PCR10,12,19,31,50




A glycolipid in myelin 110 Immunostaining10,83
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to stain endocytic synaptic vesicles and track their release
upon depolarization.23,26,77 Resting membrane potentials can
also be measured by using a cell permeant potentiometric
fluorescent dye, tetramethylrhodamine methyl ester. Intra-
cellular and extracellular fluorescence intensities obtained by
confocal imaging can be used to calculate the cells’ resting
membrane potentials.53
In summary, a combination of morphological observations,
expression level analysis of lineage specific markers and neuro-
nal activity analysis methods are suggested to be used together
in order to correctly identify the de novo differentiated
neurons.
4. Conclusion
Neural differentiation is a complex task and selective differen-
tiation into a specific subgroup of neural cells is even much
harder. Despite the complexity of the process, directing neural
cell differentiation is crucial to overcome functional loss of
neurons caused by traumatic injuries or neurodegenerative
disorders. Since conventional therapies have low rates of
success in functional recovery after neural loss, the utilization
of bioactive materials is considered as a promising approach
for neural regeneration. Biomaterials can be applied in clinics
either through the transplantation of in vitro differentiated
cells into the lesion site; or transplantation of drug/growth
factor-loaded biomaterials to direct in vivo differentiation of
endogenous stem cells. Although biomaterials containing
natural materials have the advantage of being biocompatible,
they have disadvantages due to immunological reactions and
the risk of cross-contamination. Synthetic materials can alter-
natively be used as the building blocks of scaffolds for tissue
engineering as they have the advantage of low immunogeni-
city. In order to make synthetic materials more biocompatible
and bioactive, the mechanical and chemical properties of
scaffold materials can be altered, or scaffolds can be modified
with biological signals for directing the cell fate determi-
nation. Many different approaches and methods are applied
for the development of artificial scaffolds to be used in neural
regeneration. These include the use of a variety of polymers,
alone or in combination either with a different type of polymer
or with natural materials, and the use of self-assembling syn-
thetic materials, inspired by nature, such as peptide nano-
fibers (summarized in Tables 1 and 2). Despite promising
results obtained from the application of different scaffolds,
comparative studies are required to ensure their efficiency and
safety, and to determine optimal materials and methods for
neural differentiation, so that they can be used for the treat-






BDNF Brain-derived neurotrophic factor
bFGF Basic fibroblast growth factor
BME Basement membrane extract
BMHP Bone marrow homing peptides




DMEM Dulbecco’s Modified Eagle Medium
DRG Dorsal root ganglion
ECM Extracellular matrix
EGF Epidermal growth factor




























O4 A sulfolipid (sulfatide)
found in myelin. Used as









































GAP-43 Growth-associated protein 43
GDNF Glial cell line-derived neurotrophic factor
GF Growth factor
GFAP Glial fibrillary acidic protein






MePEG-GMA Monomethyl ether-glycidyl methacrylate
MSCs Mesenchymal stem cells
NCAM Neural cell adhesion molecule
NF Neurofilament
NGF Nerve growth factor
NPC Neuronal progenitor cells
NSCs Neural stem cells




























RGLC Radial glia-like cells
SCI Spinal cord injury
SEM Scanning electron microscopy
TH Tyrosine hydroxylase
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